SELLAS Life Sciences (SLS) FCF Margin Growth (1y) (2013 - 2022)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 5,389.00
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 1,525.00
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -341.00
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 43,511.00
10 SELLAS Life Sciences 1.61 Bn 1.61 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2022 -53,484.00
Jun 30, 2015 29,148.00
Mar 31, 2015 -2,851.00
Dec 31, 2014 -17,834.00
Sep 30, 2014 2,130.00
Jun 30, 2014 -25,122.00
Mar 31, 2014 -12,605.00
Dec 31, 2013 -52,410.00
Sep 30, 2013 -14,321.00